Altimmune, Inc. (NASDAQ:ALT) Q1 2023 Earnings Call Transcript

Altimmune, Inc. (NASDAQ:ALT) Q1 2023 Earnings Call Transcript May 11, 2023

Altimmune, Inc. beats earnings expectations. Reported EPS is $-0.4, expectations were $-0.48.

Operator: Good day, ladies and gentlemen, and welcome to the Altimmune, Inc. First Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. [Operator Instructions] As a reminder,...